• VIDEO: Stereotactic ablative radiotherapy, nivolumab trial warrants further investigation

    7 days ago - By Healio

    CHICAGO - Further investigation is warranted regarding treatment with stereotactic ablative radiotherapy in combination with anti-PD-1 therapy for patients with advanced lung cancer, Makenzi Evangelist, MD, said at International Association for the Study of Lung Cancer Multidisciplinary Symposium in Thoracic Oncology. Aparna Hegde, MD, and colleagues evaluated the combination of stereotactic ablative radiotherapy plus nivolumab to determine OS and independent predictive factors for mortality in this patient population.
    Read more ...